• Info
  • Insider Ownership

Insider Trading & Ownership of David P. Schenkein

Location
Cambridge, MA
Summary
The estimated net worth of David P. Schenkein is at least $11,361,281 dollars as of 06 Jan 2026. David P. Schenkein is the Director of AGIOS PHARMACEUTICALS, INC. and owns shares of AGIOS PHARMACEUTICALS, INC. (AGIO) stock worth about $10.13M. David P. Schenkein is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $764.3K. David P. Schenkein is the Director of REGENERON PHARMACEUTICALS, INC. and owns shares of REGENERON PHARMACEUTICALS, INC. (REGN) stock worth about $465.4K.
Signature
/s/ David P. Schenkein
All Insider Reports
All Insider Reports

Notify me when David P. Schenkein files a new Insider Trading report.

⭐ Subscribe ⭐

Ownership of David P. Schenkein

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
AGIO AGIOS PHARMACEUTICALS, INC. Director $10,131,565 20 Jun 2024
DNLI Denali Therapeutics Inc. Director $764,279 03 Jun 2025
REGN REGENERON PHARMACEUTICALS, INC. Director $465,437 02 Jan 2026
PRME Prime Medicine, Inc. Director 01 Aug 2025

Insider Transactions Reported by David P. Schenkein:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.